Sale of investment securities through a review of strategic shareholdings
First written in FY2020-Q2. 6 of 13 entries say "Advanced", first in FY2020. Latest entry: 2026-05-21.
- 2026-05-21AdvancedFinancial results briefing materials
「Reduce total holdings from the perspective of improving capital efficiency and other considerations (approximately ¥600 million sold during the current fiscal year; continued consideration of further sales).」
Approximately ¥600 million of cross-shareholdings has been sold during the current fiscal year, and the Company will continue to consider further sales. - FY2024AdvancedAnnual report
「As a result, the Company sold some holdings during the fiscal year, making progress in reducing its cross-shareholdings.」
During the fiscal year, the Company sold 1 unlisted holding and 5 listed holdings, with sale proceeds from the listed holdings totaling ¥904 million. The Company continues to reduce its cross-shareholdings. - FY2024-Q2No Gain on Sales of Investment Securities RecognizedAnnual report
「Net income attributable to owners of the parent increased by ¥374 million, or 13.2%, year on year to ¥3,198 million, mainly because ordinary income increased, although extraordinary income declined as a result of lower gains on the sale of investment securities.」
No gain on sale of investment securities was recorded during the first six months, and gains on sale declined from ¥253 million in the same period of the previous year. There is no disclosure that the policy of reducing cross-shareholdings has been withdrawn. - FY2023Lower sale proceeds and gains on saleAnnual report
「As a result, the Company sold some holdings during the fiscal year, making progress in reducing its cross-shareholdings.」
During the fiscal year, the Company sold 2 holdings, recording sale proceeds of ¥1,270 million and gains on sale of ¥1,203 million. Although the scale declined from the previous fiscal year’s sale proceeds of ¥2,366 million and gains on sale of ¥2,230 million, the Company continued to reduce its cross-shareholdings. - FY2023-Q3Decrease in gains on sales of investment securitiesAnnual report
「Extraordinary income Gain on sale of investment securities 2,230 1,203」
Gains on sale of investment securities declined from ¥2,230 million in the same period of the previous year to ¥1,203 million, and gains from the sale of cross-shareholdings were below the level of the same period of the previous year. - FY2023-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 3 February 2023, the Company resolved to sell part of its investment securities as part of a review of its cross-shareholdings, and completed part of the sale on 21 and 28 April 2023. Accordingly, a gain on sale of investment securities of ¥423 million will be recorded as extraordinary income for the third quarter of the fiscal year ending September 2023.」
The Company resolved to make a new partial sale associated with its review of cross-shareholdings, and completed part of the sale in April 2023. It has reached the stage of recording a ¥423 million gain on sale of investment securities in the following quarter. - FY2022AdvancedAnnual report
「As a result, the Company sold some holdings during the fiscal year, making progress in reducing its cross-shareholdings.」
During the fiscal year, the Company sold 3 holdings, recording sale proceeds of ¥2,366 million and gains on sale of investment securities of ¥2,230 million, thereby continuing to reduce its cross-shareholdings. - FY2021AdvancedAnnual report
「As a result, the Company sold some holdings during the fiscal year, making progress in reducing its cross-shareholdings.」
During the fiscal year, the Company sold 10 holdings, recording sale proceeds of ¥2,472 million and gains on sale of investment securities of ¥2,265 million, thereby making progress in reducing its cross-shareholdings. - FY2021-Q2AchievedAnnual report
「Net income attributable to owners of the parent increased by ¥1,045 million, or 49.9%, year on year to ¥3,138 million, mainly because a gain on sale of investment securities was recorded as extraordinary income.」
Regarding the sale of investment securities associated with the review of cross-shareholdings, a gain on sale of ¥1,137 million was recorded as extraordinary income, realizing the accounting benefit. - FY2021-Q1AchievedAnnual report
「Net income attributable to owners of the parent increased by ¥411 million, or 35.1%, year on year to ¥1,583 million, mainly because a gain on sale of investment securities was recorded as extraordinary income.」
Regarding the sale of part of the cross-shareholdings resolved and carried out in the previous fiscal year, a gain on sale of investment securities of ¥1,137 million was recorded as extraordinary income, realizing the accounting benefit of the sale. - FY2020AdvancedAnnual report
「At a meeting of the Board of Directors held on 18 September 2020, the Company resolved to sell part of its investment securities as part of a review of its cross-shareholdings and carried out the sale between 4 and 25 November 2020. Accordingly, a gain on sale of investment securities of ¥1,137 million will be recorded as extraordinary income for the first quarter of the fiscal year ending September 2021.」
In addition to the ¥867 million gain on sales during the year, the Company sold part of its cross-shareholdings after the filing and reached the stage of recording a ¥1,137 million gain on sale in the first quarter of the following fiscal year. - FY2020-Q3AchievedAnnual report
「Net income attributable to owners of the parent increased by ¥1,195 million, or 39.3%, year on year to ¥4,238 million, mainly because ordinary income increased and gains on the sale of investment securities and fixed assets were recorded as extraordinary income.」
Regarding the sale of part of the cross-shareholdings resolved and carried out in the previous quarter, a gain on sale of investment securities of ¥867 million was recorded as extraordinary income, realizing the accounting benefit of the sale. - FY2020-Q2First statedAnnual report
「At a meeting of the Board of Directors held on 27 March 2020, the Company resolved to sell part of its investment securities as part of a review of its cross-shareholdings, and completed the sale on 15 April 2020. Accordingly, a gain on sale of investment securities of ¥867 million will be recorded as extraordinary income for the third quarter of the fiscal year ending September 2020.」
The Company resolved to sell and carried out the sale of part of its investment securities as part of a review of its cross-shareholdings, and plans to record a gain on sale of ¥867 million as extraordinary income in the third quarter.